Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Moses Elisaf

Showing results (201-210 of 248) with videos related to

Pageof 25
Sort By:
The Open Cardiovascular Medicine Journal|October 25, 2008
Low HDL cholesterol, smoking and IL-13 R130Q polymorphism are associated with myocardial infarction in Greek Cypriot males. A pilot studyStavroulla Xenophontos, Marilena Hadjivassiliou, Alexandros Karagrigoriou, et al.
Journal of Clinical Hypertension (Greenwich, Conn.)|July 15, 2018
Arterial damage and cognitive decline in chronic kidney disease patientsDespina Karasavvidou, Pierre Boutouyrie, Rigas Kalaitzidis, et al.
European Journal of Internal Medicine|March 16, 2011
Association of Helicobacter pylori infection with cardiovascular disease--is it just a myth?Dimitrios K Christodoulou, Haralampos J Milionis, Panagiota Pappa, et al.
Lipids|March 2, 2011
Ezetimibe treatment lowers indicators of oxidative stress in hypercholesterolemic subjects with high oxidative stressMichael S Kostapanos, Athanasia T Spyrou, Constantinos C Tellis, et al.
Archives of Medical Science : AMS|February 29, 2012
Characterization of low density lipoprotein receptor (LDLR) gene mutations in AlbaniaMaria Diakou, George Miltiadous, Stavroula Xenophontos, et al.
Expert Opinion on Therapeutic Targets|January 18, 2007
The role of renin-angiotensin system inhibition in the treatment of hypertension in metabolic syndrome: are all the angiotensin receptor blockers equal?Asterios Karagiannis, Dimitri P Mikhailidis, Vasilios G Athyros, et al.
Diabetes/Metabolism Research and Reviews|October 31, 2007
Hypertriglyceridaemic waist phenotype criteria and prevalent metabolic triad in womenIrene F Gazi, Haralampos J Milionis, Theodosios D Filippatos, et al.
Experimental and Therapeutic Medicine|June 20, 2022
Moderately elevated lipoprotein (a) levels are associated with an earlier need for percutaneous coronary intervention in recurrent cardiovascular diseaseAthanasios Hoursalas, Konstantinos Tsarouhas, Christina Tsitsimpikou, et al.
Arteriosclerosis, Thrombosis, and Vascular Biology|July 28, 2007
Differential effect of hypolipidemic drugs on lipoprotein-associated phospholipase A2Vasilios G Saougos, Afroditi P Tambaki, Mihalis Kalogirou, et al.
Maedica|December 21, 2022
The Effect of Commonly Used Fixed-Dose Single Pill Combinations of Renin-Angiotensin-System Blockers and Calcium Channel Blockers on HOMA-IR Index in Hypertensive Patients with Impaired Fasting Glucose: a 12-Week Randomized Open-Label Prospective StudyAngelos Liontos, Dimitrios Biros, Christos Papagiannopoulos, et al.
Pageof 25

Showing results (201-210 of 248) with videos related to

Sort By:
Pageof 25
The Open Cardiovascular Medicine Journal|October 25, 2008
Low HDL cholesterol, smoking and IL-13 R130Q polymorphism are associated with myocardial infarction in Greek Cypriot males. A pilot studyStavroulla Xenophontos, Marilena Hadjivassiliou, Alexandros Karagrigoriou, et al.
Journal of Clinical Hypertension (Greenwich, Conn.)|July 15, 2018
Arterial damage and cognitive decline in chronic kidney disease patientsDespina Karasavvidou, Pierre Boutouyrie, Rigas Kalaitzidis, et al.
European Journal of Internal Medicine|March 16, 2011
Association of Helicobacter pylori infection with cardiovascular disease--is it just a myth?Dimitrios K Christodoulou, Haralampos J Milionis, Panagiota Pappa, et al.
Lipids|March 2, 2011
Ezetimibe treatment lowers indicators of oxidative stress in hypercholesterolemic subjects with high oxidative stressMichael S Kostapanos, Athanasia T Spyrou, Constantinos C Tellis, et al.
Archives of Medical Science : AMS|February 29, 2012
Characterization of low density lipoprotein receptor (LDLR) gene mutations in AlbaniaMaria Diakou, George Miltiadous, Stavroula Xenophontos, et al.
Expert Opinion on Therapeutic Targets|January 18, 2007
The role of renin-angiotensin system inhibition in the treatment of hypertension in metabolic syndrome: are all the angiotensin receptor blockers equal?Asterios Karagiannis, Dimitri P Mikhailidis, Vasilios G Athyros, et al.
Diabetes/Metabolism Research and Reviews|October 31, 2007
Hypertriglyceridaemic waist phenotype criteria and prevalent metabolic triad in womenIrene F Gazi, Haralampos J Milionis, Theodosios D Filippatos, et al.
Experimental and Therapeutic Medicine|June 20, 2022
Moderately elevated lipoprotein (a) levels are associated with an earlier need for percutaneous coronary intervention in recurrent cardiovascular diseaseAthanasios Hoursalas, Konstantinos Tsarouhas, Christina Tsitsimpikou, et al.
Arteriosclerosis, Thrombosis, and Vascular Biology|July 28, 2007
Differential effect of hypolipidemic drugs on lipoprotein-associated phospholipase A2Vasilios G Saougos, Afroditi P Tambaki, Mihalis Kalogirou, et al.
Maedica|December 21, 2022
The Effect of Commonly Used Fixed-Dose Single Pill Combinations of Renin-Angiotensin-System Blockers and Calcium Channel Blockers on HOMA-IR Index in Hypertensive Patients with Impaired Fasting Glucose: a 12-Week Randomized Open-Label Prospective StudyAngelos Liontos, Dimitrios Biros, Christos Papagiannopoulos, et al.
Pageof 25